Showing results (571-580 of 1,291) with videos related to
Sort By:
Pageof 130
Journal of Comparative Effectiveness Research|November 10, 2022
Healthcare and economic burden of anticholinergic use in adults with overactive bladder: a systematic literature reviewCorinne Duperrouzel, Coby Martin, Ari Mendell, et al.Journal of Comparative Effectiveness Research|February 7, 2023
Disease progression rates in ambulatory Duchenne muscular dystrophy by steroid type, patient age and functional statusCraig M McDonald, Jessica R Marden, Perry B Shieh, et al.Journal of Comparative Effectiveness Research|February 27, 2023
Comparative efficacy and safety among high-intensity statins. Systematic Review and Meta-AnalysisMyriam Jaam, Hend Nasser Al-Naimi, Moumena Mahmoud Haddad, et al.Journal of Comparative Effectiveness Research|February 19, 2025
The role of health economic evidence in clinical practice guidelines for colorectal cancer: a comparative analysis across countriesXiaoyu Yan, Yue Wang, Aixia Ma, et al.Journal of Comparative Effectiveness Research|February 20, 2025
Comparison of real-world healthcare resource utilization and costs among patients with hereditary angioedema on lanadelumab or berotralstat long-term prophylaxisNicole Princic, Kristin A Evans, Chintal H Shah, et al.Journal of Comparative Effectiveness Research|January 29, 2025
Budget impact analyses of hemoglobin A1c and lipid panel point-of-care testing with Afinion™ 2 in Canada and ItalyDavid Garcia, Antonio Ruffolo, Alicyia Walczyk Mooradally, et al.Journal of Comparative Effectiveness Research|January 21, 2025
A real-world analysis of antidepressant medications in US veterans aged 60 years and older: a comparative analysisRyan D Pittman, S Scott Sutton, Joseph Magagnoli, et al.Journal of Comparative Effectiveness Research|January 21, 2025
MOMENT registry: Patients with advanced non-small-cell lung cancer harboring MET exon 14 skipping treated with systemic therapyMichael Thomas, Petros Christopoulos, Wade T Iams, et al.Journal of Comparative Effectiveness Research|January 21, 2025
Longer disease progression milestone-free time in people with amyotrophic lateral sclerosis treated versus not treated with intravenous edaravone: results from an administrative claims analysisJames D Berry, Melissa Hagan, Jeffrey Zhang, et al.Journal of Comparative Effectiveness Research|November 5, 2024
The economic impact associated with stent retriever selection for the treatment of acute ischemic stroke: a cost-effectiveness analysis of MASTRO I data from a Chinese healthcare system perspectiveOsama O Zaidat, Xinguang Yang, Waleed Brinjikji, et al.Pageof 130